Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 1/20 | 0.44 |
| ▸ | YAP1 | P46937 | 3/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 3/20 | 0.40 |
| ▸ | GHSR | Q92847 | 3/20 | 0.40 |
| ▸ | KDM1A | O60341 | 2/20 | 0.40 |
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8229952 | 0.86 | YAP1 (0.40) | MMP13YAP1TP53PRMT5GHSR | |
| SCHEMBL6861570 | 0.86 | YAP1 (0.40) | MMP13YAP1TP53PRMT5GHSR | |
| SCHEMBL6861568 | 0.80 | YAP1 (0.41) | MMP13YAP1TP53PRMT5MEN1 | |
| SCHEMBL13701098 | 0.77 | YAP1 (0.44) | MMP13YAP1TP53PRMT5MAOB | |
| SCHEMBL13701096 | 0.77 | YAP1 (0.47) | YAP1TP53PRMT5KDM4EMAOB | |
| SCHEMBL13701121 | 0.77 | YAP1 (0.43) | MMP13YAP1TP53PRMT5GHSR | |
| SCHEMBL5887627 | 0.75 | YAP1 (0.44) | YAP1PRMT5MEN1KMT2AMAOB | |
| SCHEMBL21877176 | 0.75 | YAP1 (0.52) | YAP1PRMT5MAOB | |
| SCHEMBL22546600 | 0.75 | MAOB (0.44) | YAP1PRMT5MAOBGHSR | |
| SCHEMBL16874776 | 0.74 | YAP1 (0.54) | YAP1PRMT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1004578-B1 | 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives | PFIZER PROD INC (US) | 2004-02-25 | — | — | EP | disclosed |
| US-6114361-A | INHIBITORS OF MATRIX METALLOPROTEINASES AND REPROLYSIN; ADMINISTERING TO TREAT CONDITIONS WHICH CAN BE TREATED BY THE INHIBITION OF THESE ENZYMES | PFIZER INC. (US) | 2000-09-05 | — | — | US | disclosed |
| EP-1004578-A2 | 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives | Pfizer Products Inc. (US) | 2000-05-31 | — | — | EP | disclosed |